310 22. Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ (2007) Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res 1181:93–103 23. Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10:1369–1376 24. Kalaria RN (2009) Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer’s disease. Neurobiol Aging 30:1512–1514 25. Kalaria RN (2009) Neurodegenerative disease: diabetes, micro- vascular pathology and Alzheimer disease. Nat Rev Neurol 5:305–306 26. Kalaria RN, Harik SI (1989) Reduced glucose transporter at the blood–brain barrier and in cerebral cortex in Alzheimer’s disease. J Neurochem 53:1083–1088 27. Kasai S, Urushibata S, Hozumi K et al (2007) Identiﬁcation of multiple amyloidogenic sequences in laminin-1. Biochemistry 46:3966–3974 28. Knobloch M, Konietzko U, Krebs DC, Nitsch RM (2007) Intra- cellular Ab and cognitive deﬁcits precede b-amyloid deposition in transgenic arcAb mice. Neurobiol Aging 28:1297–1306 29. Kuhr WG, Korf J (1988) Extracellular lactic acid as an indicator of brain metabolism: continuous on-line measurement in con- scious, freely moving rats with intrastriatal microdialysis. J Cereb Blood Flow Metab 8:130–137 30. Kumar-Singh S (2009) Hereditary and sporadic forms of Ab- cerebrovascular amyloidosis and relevant transgenic mouse models. Internat J Mol Sci 10:1872–1895 31. Lord A, Englund H, So¨derberg L et al (2009) Amyloid b proto- ﬁbril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice. FEBS J 276:995–1006 32. Maekawa F, Minehira K, Kadomatsu K, Pellerin L (2008) Basal and stimulated lactate ﬂuxes in primary cultures of astrocytes are differentially controlled by distinct proteins. J Neurochem 107:789–798 33. Maurer MH, Canis M, Kuschinsky W, Duelli R (2004) Correla- tion between local monocarboxylate transporter 1 (MCT1) and glucose transporter 1 (GLUT1) densities in the adult rat brain. Neurosci Lett 355:105–108 34. Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T (2008) Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer’s disease. Proc Natl Acad Sci USA 105:3587–3592 35. Nilsberth C, Westlind-Danielsson A, Eckman CB et al (2001) The ‘‘Arctic’’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Ab protoﬁbril formation. Nat Neurosci 4:887–893 36. Palu E, Liesi P (2002) Differential distribution of laminins in Alzheimer disease and normal human brain tissue. J Neurosci Res 69:243–256 37. Pellerin L (2005) How astrocytes feed hungry neurons. Mol Neurobiol 32:59–72 38. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilisation. Proc Natl Acad Sci USA 91:10625–10629 39. Persson L, Hansson H-A, Sourander P (1976) Extravasation, spread and cellular uptake of Evans blue-labelled albumin around a reproducible small stab-wound in the rat brain. Acta Neuro- pathol 34:125–136 40. Pezzini A, Del Zotto E, Volonghi I, Giossi A, Costa P, Padovani A (2009) Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem 16:2498–2513 41. Pierre K, Pellerin L, Debernardi R, Riederer BM, Magistretti PJ (2000) Cell-speciﬁc localisation of monocarboxylate transporters, MCT1 and MCT2, in the adult mouse brain revealed by double 123 Acta Neuropathol (2011) 122:293–311 immunohistochemical labeling and confocal microscopy. Neu- roscience 100:617–627 42. Ro¨nnba¨ck A, Zhu S, Dillner K et al (2011) Progressive neuro- pathology and cognitive decline in a single Arctic APP transgenic mouse model. Neurobiol Aging 32:280–292 43. Schurr A, Miller JJ, Payne RS, Rigor BM (1999) An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons. J Neurosci 19:34–39 44. Schurr A (2006) Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab 26:142–152 45. PhDTB Shea, Beerman ML, Honda T, Nixon RA (1993) Secre- tion of amyloid precursor protein and laminin by cultured astrocytes is inﬂuenced by culture conditions. J Neurosci Res 37:197–207 46. Simpson IA, Carruthers A, Vannucci SJ (2007) Supply and demand in cerebral metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 27:1766–1791 47. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer’s disease. Ann Neurol 35:546–551 48. Simpson JE, Ince PG, Lace G et al (2010) Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neu- robiol Aging 31:578–590 49. Smith EE, Greenberg SM (2009) b-amyloid, blood vessels, and brain function. Stroke 40:2601–2606 50. Steele ML, Robinson SR (2010) Reactive astrocytes give neurons less support: implications for Alzheimer’s disease. Neurobiol Aging (in press) 51. Suhara T, Magrane´ J, Rosen K et al (2003) Abeta42 generation is toxic to endothelial cells and inhibits eNOS function through an Akt/GSK-3beta signalling-dependent mechanism. Neurobiol Aging 24:437–451 52. Thal DR, Grifﬁn WST, de Vos RAI, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease. Acta Neuropathol 115:599–609 53. Tian M, Jacobson C, Gee SH, Campbell KP, Carbonetto S, Jucker M (1996) Dystroglycan in the cerebellum is a laminin a2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci 8:2739–2747 54. Vagnucci AH Jr, Li DW (2003) Alzheimer’s disease and angio- genesis. Lancet 361:605–608 55. Van Dorpe J, Smeijers L, Dewachter I et al (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons. Am J Pathol 157:1283–1298 56. Wang DD, Bordey A (2008) The astrocyte odyssey. Prog Neu- robiol 86:342–367 57. Weller RO, Boche D, Nicoll JAR (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102 58. Weller RO, Massey A, Newman TA, Hutchings M, Kuo Y-M, Roher AE (1998) Amyloid beta accumulates in putative inter- stitial ﬂuid drainage pathways in Alzheimer’s disease. Am J Pathol 153:725–733 59. Weller RO, Preston SD, Subash M, Carare RO (2009) Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alz Res Ther 1:6 60. White JA, Manelli AM, Holmberg KH, Van Eldik LJ, LaDu MJ (2005) Differential effects of oligomeric and ﬁbrillar amyloid-b1- 42 on astrocyte mediated inﬂammation. Neurobiol Dis 18:459–465 61. Wilcock DM, Vitek MP, Colton CA (2009) Vascular amyloid alters astrocytic water and potassium channels in mouse models